Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Enrolling By Invitation NCT07880015

Digital Phenotypes for Predicting Depression_Validation

Conditions: Major Depressive Disorder, Bipolar I Disorder, Bipolar II Disorder, Mood Disorders

Sex: All
Ages: 19 Years – 75 Years
Healthy volunteers: Yes
Enrollment: 200
Sponsor: Korea University Anam Hospital

Location: Korea University Anam Hospital Seoul Seongbuk-gu

Summary

This 12-month, single-site prospective observational study will prospectively monitor the recurrence of mood episodes while continuously collecting passive digital phenotypes in individuals with and without mood disorders. A total of 200 adults will be enrolled, including 100 patients with major depressive disorder or bipolar I/II disorder and 100 healthy control participants. Participants will complete five clinical assessments at 3-month intervals and will continuously wear a consumer wearable device and use the My Mental HERO smartphone application for passive sensing and daily mood recording. Structured clinical interviews will identify the occurrence, subtype, and day-level onset and offset of mood episodes during follow-up. The study will examine longitudinal digital phenotypes associated with mood states and subsequent mood episode onset. It is designed to provide an independent validation dataset for digital phenotypes and prediction models developed in the preceding MentalHERO prospective observational cohort (ClinicalTrials.gov Identifier: NCT07151846). Because the two cohorts follow closely aligned study protocols and assessment schedules, data from both cohorts may also be pooled for secondary analyses where appropriate.

Eligibility Criteria

Patient group 1. Adults aged 19-75 years. 2. Meets DSM-5 diagnostic criteria for major depressive disorder, bipolar I disorder, or bipolar II disorder, and has a history of visiting a psychiatric clinic for symptoms related to the disorder. 3. Has experienced at least one major depressive episode in the past. 4. Owns and is able to use an internet-connected smartphone and agrees to wear the study-provided wearable device daily throughout the study period and to complete daily mood recordings through the digital phenotyping application. Healthy control group 1. Adults aged 19-75 years. 2. Has no current or past diagnosis of major depressive disorder, bipolar I disorder, or bipolar II disorder. 3. Has a baseline Patient Health Questionnaire-9 (PHQ-9) score \

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07880015). StuddyBuddy aggregates publicly available trial information.